Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/06/2000CA2308793A1 Composition containing at least one aromatic bicyclic compound and at least one lipophilic solar filter, and its uses
11/03/2000CA2270600A1 Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
11/02/2000WO2000066152A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000WO2000065346A1 Diagnosis of human kidney diseases
11/02/2000WO2000065073A2 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065046A1 Pollinosis-associated gene 373
11/02/2000WO2000065045A1 Pollinosis-associated gene 419
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000064977A1 In situ forming hydrogels
11/02/2000WO2000064921A2 Process of purifying phytosterols from wood or plant-derived sources by means of metal salt complexes and compositions resulting therefrom
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064900A1 Pyrazolobenzodiazepines as cdk2 inhibitors
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064898A1 Azaindole derivatives for the treatment of depression
11/02/2000WO2000064897A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
11/02/2000WO2000064896A1 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064893A2 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000WO2000064892A2 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064887A1 Renin inhibitors
11/02/2000WO2000064885A1 Heteroaryl diazacycloalkanes, their preparation and use
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064877A1 2-aminoquinolinecarboxamides: neurokinin receptor ligands
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064875A1 Method for pulvirizing to fine powder
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064873A1 Renin inhibitors
11/02/2000WO2000064869A1 Vitamin d analogues and their pharmaceutical use
11/02/2000WO2000064866A1 Diphenylurea derivatives
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000064859A1 Amide derivatives
11/02/2000WO2000064854A1 Conjugated fatty acid esters
11/02/2000WO2000064520A1 Powder inhaler for combined medicament
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064487A2 Delivery of antimicrobial toxins
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000064479A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
11/02/2000WO2000064478A1 Preventives/remedies for liver diseases
11/02/2000WO2000064477A1 Preventives/remedies for angiostenosis
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064468A2 Therapeutic compositions and methods for enhancing angiogenesis
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064463A1 PSYCHOTROPIC POLYGALASAPONINS, AND ITS EXTRACTION AND ISOLATION FROM $i(POLYGALAE RADIX)
11/02/2000WO2000064462A1 Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for dementia
11/02/2000WO2000064456A2 Substitution infusion fluid and citrate anticoagulation
11/02/2000WO2000064455A1 Method of enhancing the efficacy of anti-tumor agents
11/02/2000WO2000064454A2 Pharmaceutical composition comprising an inositol and a metal ion for improving insulin sensitivity and glucose metabolism
11/02/2000WO2000064453A1 Intestinal fermentation sulfide deodorizers
11/02/2000WO2000064452A1 Increased fertility and improved fetal development drug
11/02/2000WO2000064451A1 Use of tagatose to enhance key blood factors
11/02/2000WO2000064450A1 Pharmaceutical composition
11/02/2000WO2000064449A1 Thrombin inhibitors
11/02/2000WO2000064448A1 A composition and method for treatment of cerebral ischemia
11/02/2000WO2000064447A1 Novel compositions comprising trimetrexate and methods of their synthesis and use
11/02/2000WO2000064446A1 Noscapine derivatives as adjuvant compositions and methods of use thereof
11/02/2000WO2000064445A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000WO2000064444A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
11/02/2000WO2000064443A1 Synergistic effects of amlodipine and atorvastatin
11/02/2000WO2000064442A1 Novel anticoagulant injectable composition
11/02/2000WO2000064441A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction
11/02/2000WO2000064440A1 Treatment of and/or prophylaxis against brain and spinal cord injury
11/02/2000WO2000064439A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
11/02/2000WO2000064438A1 Cardiovascular and bone treatment using isoflavones
11/02/2000WO2000064437A1 Long term administration of pharmacologically active agents
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064435A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000WO2000064434A1 Percutaneous preparations containing oxybutynin
11/02/2000WO2000064433A1 Ketoprofen microgranules, preparation method and pharmaceutical compositions
11/02/2000WO2000064432A1 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
11/02/2000WO2000064431A1 Pharmaceutical compositions of tetrac and methods of use thereof
11/02/2000WO2000064430A1 Apoptosis inhibitors
11/02/2000WO2000064429A1 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa
11/02/2000WO2000064428A2 Polyether-based bile acid sequestrants
11/02/2000WO2000064427A2 Lamivudine containing pharmaceutical formulation
11/02/2000WO2000064426A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
11/02/2000WO2000064424A2 Cystic fibrosis medicaments
11/02/2000WO2000064423A2 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
11/02/2000WO2000064422A2 Novel treatment of neurotraumatic conditions with raf inhibitor
11/02/2000WO2000064421A2 Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000064419A1 Transdermal therapeutic system with a highly effective neuroleptic agent
11/02/2000WO2000064418A2 Transdermal therapeutic system with neutralized acrylic adhesive patch
11/02/2000WO2000064416A2 Pharmaceutical formulation of tamoxifen citrate
11/02/2000WO2000064415A1 Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
11/02/2000WO2000064414A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000WO2000064413A1 Antibody and polyalkylene glycol-bonded liposome
11/02/2000WO2000064405A2 Treating hair by targeting enzymes
11/02/2000WO2000064274A1 Fish feed
11/02/2000WO2000064273A1 Complete feed for fish larvae and method for preparing same
11/02/2000WO2000064260A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000WO2000048554A3 Synergistic antimicrobial skin washing compositions
11/02/2000WO2000046235B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
11/02/2000WO2000042987A3 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
11/02/2000WO2000042982A8 Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
1 ... 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 ... 7860